Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47296

Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117

Email jamie-miller@ouhsc.edu


Publications & Presentations

    56. Capino A C, Johnson P N, Williams P K, Anderson M P, Bedwell S, Miller J L. Pilot Study Comparing Modified Finnegan Scoring Versus Adjusted Scoring System for Infants With Iatrogenic Opioid Abstinence Syndrome After Cardiothoracic Surgery. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2019; 24 : 148-155

    57. Capino A C, Johnson P N, Williams P K, Anderson M, Bedwell S, Miller J L. Pilot Study Comparing Modified Finnegan Scoring Versus Adjusted Scoring System for Infants With Iatrogenic Opioid Abstinence Syndrome After Cardiothoracic Surgery. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2019; 24 : 148-155

    58. Medina M, Schwier N C, Miller J L, Miller M M, Skrepnek G. Career skills assessment in a doctor of pharmacy curriculum. American Journal of Pharmacy Education. 2018; 82 : 6300

    59. Autry M, Harrison K, White B, Miller J L. Liposomal amphotericin b-associated cardiac arrest: case report and literature review. Infectious Diseases in Clinical Practice/Wolters Kluwer Health. 2018; 26 : 326-330

    60. Miller J L, Johnson P N, White B P, Neely S, Chaaban H, Kassa N, Welliver, Sr R C. Impact of Ceftazidime Use on Susceptibility Patterns in the Neonatal Intensive Care Unit. The Pediatric infectious disease journal. 2018




Grants

    1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.




Awards and Honors

<< 1 2
                                                                                            6. Pediatric Pharmacy Advocacy Group. Outstanding Original Research Award. Date: 2018.  

                                                                                            7. Pediatric Pharmacy Advocacy Group. Scholarship in Teaching Award. Date: 2018.  

                                                                                            8. Pediatric Pharmacy Advocacy Group. Christensen Memorial Young Investigator Award (Resident Mentor). Date: 2016.  

                                                                                            9. Pediatric Pharmacy Advocacy Group. Outstanding Original Paper. Date: 2014.  

<< 1 2



Education

                                                                                            1.  Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.  

                                                                                            2.  Degree: BS. Trevecca Nazarene University. Date: 2002.  




Administrative Assignments

                                                

    1. Role: Department Vice-Chair. Scope: Department. Date: 2021.